Robert Jones

Vice President, Global Bioservices • cryoport systems

Rob is an accomplished Commercial Director with a proven track record in the life sciences and advanced therapy industry. He possesses strong expertise in Good Manufacturing Practice (GMP), Cryogenic supply chain, clinical trials, Vaccines, Validation, and Oncology. 

His journey in the field of life sciences began with a qualification in Haematology and Blood Transfusion Medicine, and he gained valuable experience working at the UK Blood Transfusion Service in the Birmingham laboratories. He further honed his skills in a technical support role at DuPont Virology Diagnostics before transitioning into commercial positions at Sorvall Inc and Kendro Laboratory Products. 

In 2004, Rob seized the opportunity to establish the first commercial biorepository in the UK, which was later acquired by Thermo Fisher Scientific and became Fisher Bioservices UK. Currently, he leads a new Global business division at Cryoport Systems Inc, where he specializes in ultra-cold and cryogenic supply chain support services. His expertise and leadership have contributed significantly to the growth and success of the company in this specialized field. 

Also speaking

Rachel Abbott

Chief Executive Officer • Pan Cancer T

Hanna P. Lesch

Chief Technology Officer • Exothera SA

Luís Pereira de Almeida

Professor & Group Leader • University of Coimbra

Event Info


Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.